Publications

  1. Malsch RM, Dalvin LA. A White Reflex in a Previously Healthy 21-Month-Old Boy. Pediatr Rev. 2025 May 1; 46 (5):e17-e21
    View PubMed
  2. Wang KY, Kim BM, Yu CY, Welk GM, Churchill RA, White LJ, Hodge DO, Dalvin LA, Tooley AA. Clinical characteristics and outcomes of primary orbital lymphoma. Eur J Ophthalmol. 2025 Apr 29; 11206721251338705 [Epub ahead of print]
    View PubMed
  3. Swaminathan VB, Kaplan TM, Dalvin LA. Bilateral Exudative Retinal Detachments from Secondary Choroidal Lymphoma. Ophthalmol Retina. 2025 Apr 17 [Epub ahead of print]
    View PubMed
  4. Chang EL, Liu R, Keyhanian K, Huynh K, Berkenstock M, Bhatti MT, Chen JJ, Chodosh J, Costello F, Dalvin LA, DeLott LB, Dinkin M, Egan RA, Fraser CL, Freitag SK, Gangaputra S, Gordon LK, Guidon AC, Johnson DB, Kombo N, Kramer M, Lee AG, Levy M, Lobo-Chan AM, Mantopoulos D, Papaliodis G, Pless M, Pimkina J, Rubin KM, Sen HN, Shariff A, Subramanian PS, Tsui E, Yoon MK, McDunn J, Rine J, Reynolds KL, Sobrin L, Chwalisz BK. Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2025 Apr 8; 13 (4) Epub 2025 Apr 08
    View PubMed
  5. Bahr T, Krivit J, Salomao DR, Baratz KH, Dalvin LA. Conjunctival Melanoma With Invasion of a LASIK Flap Interface. JAMA Ophthalmol. 2025 Mar 27 [Epub ahead of print]
    View PubMed
  6. Malsch RM, Patel SV, Trejo-Lopez JA, Dalvin LA. An amelanotic conjunctival lesion in a 40-year-old man. Can J Ophthalmol. 2025 Mar 21 [Epub ahead of print]
    View PubMed
  7. Tailor PD, Dalvin LA, Starr MR, Tajfirouz DA, Chodnicki KD, Brodsky MC, Mansukhani SA, Moss HE, Lai KE, Ko MW, Mackay DD, Di Nome MA, Dumitrascu OM, Pless ML, Eggenberger ER, Chen JJ. A Comparative Study of Large Language Models, Human Experts, and Expert-Edited Large Language Models to Neuro-Ophthalmology Questions. J Neuroophthalmol. 2025 Mar 1; 45 (1):71-77 Epub 2024 Apr 02
    View PubMed
  8. Ramos-Davila EM, Dalvin LA. Clinical Implications of Ultrasound-Based Morphology in Choroidal Melanoma. Ophthalmol Retina. 2025 Mar; 9 (3):263-271 Epub 2024 Sept 24
    View PubMed
  9. Bui NT, Dalvin LA, Howard SL, Hall JP, Sit AJ, Zhang X. A noninvasive ultrasound vibro-elastography technique for assessing ocular lesions. Ultrasonics. 2025 Mar; 147:107525 Epub 2024 Nov 19
    View PubMed
  10. Ferenchak K, Guerin JB, Nayab A, Keating GF, Lopour MQ, Dalvin LA, Schimmenti LA, Scruggs BA, Silvera VM. Norrie Disease: Cochlear Enhancement and Cerebellar Signal Abnormalities. AJNR Am J Neuroradiol. 2025 Feb 18 [Epub ahead of print]
    View PubMed
  11. Malsch RM, Tessem RB, Dalvin LA. Insights from the First Five Years of the Prospective Ocular Tumor Study. Semin Ophthalmol. 2025 Jan 28; 1-10 [Epub ahead of print]
    View PubMed
  12. Tailor PD, Kopinski PK, D'Souza HS, Leske DA, Olsen TW, Shields CL, Shields JA, Dalvin LA. Predicting Choroidal Nevus Transformation to Melanoma Using Machine Learning. Ophthalmol Sci. 2025 Jan-Feb; 5 (1):100584 Epub 2024 July 20
    View PubMed
  13. Edalat C, Kirupaharan N, Dalvin LA, Mishra K, Marshall R, Xu H, Francis JH, Berkenstock M. EVALUATING LARGE LANGUAGE MODELS ON THEIR ACCURACY AND COMPLETENESS: Immune Checkpoint Inhibitors and Their Ocular Toxicities. Retina. 2025 Jan 1; 45 (1):128-132
    View PubMed
  14. Dalvin LA, Andrews-Pfannkoch CM, Miley DR, Hogenson TL, Erickson SA, Malpotra S, Anderson KJ, Omer ME, Almada LL, Zhang C, Li H, Salomao DR, Shields CL, Lally SE, Malsch RM, Armitage JA, Holmes HL, Romero MF, Fautsch MP, Markovic SN, Fernandez-Zapico ME. Novel Uveal Melanoma Patient-Derived Organoid Models Recapitulate Human Disease to Support Translational Research. Invest Ophthalmol Vis Sci. 2024 Nov 4; 65 (13):60
    View PubMed
  15. Salman AR, Smith WM, Olsen TW, Dalvin LA. Intraocular sarcoid-like reaction in patients with chronic lymphocytic leukemia. Can J Ophthalmol. 2024 Oct; 59 (5):335-340 Epub 2023 Dec 29
    View PubMed
  16. Salman AR, Salomao DR, Dalvin LA, Olsen TW, Smith WM. Ocular Whipple Disease: Cases Diagnosed Over Four Decades. Ocul Immunol Inflamm. 2024 Oct; 32 (8):1863-1868 Epub 2023 Nov 02
    View PubMed
  17. Wang KY, Xu TT, Mogil RS, Song AJ, White LJ, Hodge DO, Dalvin LA. FACTORS ASSOCIATED WITH DELAYED DIAGNOSIS IN PATIENTS WITH PRIMARY VITREORETINAL LYMPHOMA. Retina. 2024 Oct 1; 44 (10):1800-1806
    View PubMed
  18. Wang KY, Xu TT, Dumbrava MG, Oyemade KA, Lopez Dominguez J, Hodge DO, White LJ, Tooley AA, Dalvin LA. Population-Based Incidence and Clinical Characteristics of Ocular Adnexal Tumors in Olmsted County, Minnesota. Ophthalmic Epidemiol. 2024 Aug 30; 1-8 [Epub ahead of print]
    View PubMed
  19. Marshall R, Xu H, Dalvin LA, Mishra K, Edalat C, Kirupaharan N, Francis JH, Berkenstock M. Accuracy and Completeness of Large Language Models About Antibody-Drug Conjugates and Associated Ocular Adverse Effects. Cornea. 2024 Aug 7 Epub 2024 Aug 07
    View PubMed
  20. Verbeek S, Dalvin LA. Advances in multimodal imaging for diagnosis of pigmented ocular fundus lesions. Can J Ophthalmol. 2024 Aug; 59 (4):218-233 Epub 2023 July 19
    View PubMed
  21. Zeiger JS, Lally SE, Dalvin LA, Shields CL. Advances in conjunctival melanoma: clinical features, diagnostic modalities, staging, genetic markers, and management. Can J Ophthalmol. 2024 Aug; 59 (4):209-217 Epub 2023 Mar 12
    View PubMed
  22. Tailor PD, Dalvin LA, Chen JJ, Iezzi R, Olsen TW, Scruggs BA, Barkmeier AJ, Bakri SJ, Ryan EH, Tang PH, Parke DW 3rd, Belin PJ, Sridhar J, Xu D, Kuriyan AE, Yonekawa Y, Starr MR. A Comparative Study of Responses to Retina Questions from Either Experts, Expert-Edited Large Language Models, or Expert-Edited Large Language Models Alone. Ophthalmol Sci. 2024 Jul-Aug; 4 (4):100485 Epub 2024 Feb 06
    View PubMed
  23. El Zein L, Smith WM, White LJ, Hodge DO, Olsen TW, Pulido JS, Dalvin LA. Optical coherence tomography features in vitreoretinal lymphoma compared with non-infectious uveitis. BMC Ophthalmol. 2024 Jun 13; 24 (1):255 Epub 2024 June 13
    View PubMed
  24. McDonald JA, Barkmeier AJ, Dalvin LA, Scruggs BA. Focal choroidal excavation (FCE)-related choroidal neovascular membrane (CNV) in a child. Retin Cases Brief Rep. 2024 Jun 11 Epub 2024 June 11
    View PubMed
  25. Adams OE, Tanke LB, Mundae R, Sodhi GS, Yu MD, Yonekawa Y, Dalvin LA, Tang PH. Trends in the Clinical Presentation of Uveal Melanoma During the COVID-19 Pandemic. Ophthalmic Surg Lasers Imaging Retina. 2024 May; 55(5):278-284. Epub 2024 Mar 01.
    View PubMed
  26. Shah SM, Tanke LB, Deufel CL, Petersen IA, Corbin KS, Hodge DO, Olsen TW, Dalvin LA. Central subfield thickness predicts visual acuity outcomes in plaque-irradiated eyes with choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 2024 Apr; 262 (4):1305-1320 Epub 2023 Nov 11
    View PubMed
  27. Tailor PD, Xu TT, Fortes BH, Iezzi R, Olsen TW, Starr MR, Bakri SJ, Scruggs BA, Barkmeier AJ, Patel SV, Baratz KH, Bernhisel AA, Wagner LH, Tooley AA, Roddy GW, Sit AJ, Wu KY, Bothun ED, Mansukhani SA, Mohney BG, Chen JJ, Brodsky MC, Tajfirouz DA, Chodnicki KD, Smith WM, Dalvin LA. Appropriateness of Ophthalmology Recommendations From an Online Chat-Based Artificial Intelligence Model. Mayo Clin Proc Digit Health. 2024 Mar; 2 (1):119-128 Epub 2024 Feb 15
    View PubMed
  28. Churchill RA, Pecoraro TYC, Tooley AA, Houghton OM, Mashayekhi A, Dalvin LA. Multimodal imaging risk factors predictive of small choroidal melanocytic lesion growth to melanoma: An educational study and pictorial guide. Eye (Lond). 2024 Mar; 38 (4):798-805 Epub 2023 Oct 25
    View PubMed
  29. D'Souza HS, Dalvin LA, Wagner LH. Esophageal Adenocarcinoma Metastatic to the Choroid with Extrascleral Extension. Ophthalmology. 2024 Feb; 131(2):207. Epub 2023 May 24.
    View PubMed
  30. Balasubramaniam SC, Dalvin LA, Bakri SJ. Prevalence of intraocular tumours detected by ultrasonography in eyes with opaque media. Can J Ophthalmol. 2024 Feb; 59(1):46-49. Epub 2022 Oct 14.
    View PubMed
  31. Adusei SA, Sabeti S, Larson NB, Dalvin LA, Fatemi M, Alizad A. Quantitative Biomarkers Derived from a Novel, Contrast-Free Ultrasound, High-Definition Microvessel Imaging for Differentiating Choroidal Tumors. Cancers (Basel). 2024 Jan 17; 16 (2)
    View PubMed
  32. Parra-Bernal C, Aguilera-Partida JA, Dalvin LA, Rodriguez-Reyes AA, Ancona-Lezama D. Beneath the surface: a case report of metastatic iridociliary ring melanoma treated with pembrolizumab. Arq Bras Oftalmol. 2024; 86 (5):e20230046 Epub 2024 Jan 22
    View PubMed
  33. Wang KY, Xu TT, White LJ, Dalvin LA. Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses. Ocul Oncol Pathol. 2023 Dec; 9(5-6):158-165. Epub 2023 Oct 26.
    View PubMed
  34. Masoomian B, Dalvin LA, Riazi-Esfahani H, Ghassemi F, Azizkhani M, Mirghorbani M, Khorrami-Nejad M, Sajjadi Z, Kaliki S, Sagoo MS, Al Harby L, Al-Jamal RT, Kivela TT, Giblin M, Lim LS, Shields CL. Pediatric ocular melanoma: a collaborative multicenter study and meta-analysis. J AAPOS. 2023 Dec; 27 (6):316-324 Epub 2023 Nov 08
    View PubMed
  35. Qureshi MB, Lentz PC, Xu TT, White LJ, Olsen TW, Pulido JS, Dalvin LA. Choroidal Nevus Features Associated with Subspecialty Referral. Ophthalmol Retina. 2023 Dec; 7 (12):1097-1108 Epub 2023 July 29
    View PubMed
  36. Kaplan TM, Starr MR, Dalvin LA. Hyperviscosity retinopathy from chronic myelogenous leukemia. Can J Ophthalmol. 2023 Dec; 58 (6):e245-e246 Epub 2023 July 20
    View PubMed
  37. Miley DR, Andrews-Pfannkoch CM, Pulido JS, Erickson SA, Vile RG, Fautsch MP, Marmorstein AD, Dalvin LA. Direct early growth response-1 knockdown decreases melanoma viability independent of mitogen-activated extracellular signal-related kinase inhibition. Melanoma Res. 2023 Dec 1; 33 (6):482-491 Epub 2023 Aug 25
    View PubMed
  38. Oyemade KA, Xu TT, Lopez Dominguez J, Dumbrava MG, Hodge DO, White LJ, Dalvin LA. Population-based incidence of intraocular tumours in Olmsted County, Minnesota. Br J Ophthalmol. 2023 Sep; 107 (9):1369-1376 Epub 2022 Apr 21
    View PubMed
  39. Salman AR, Ferenchak K, Olsen TW, Smith WM, Ketterling RP, McPhail ED, Salomao DR, Dalvin LA. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION. Retin Cases Brief Rep. 2023 Sep 1; 17 (5):572-576
    View PubMed
  40. Wang KY, Xu TT, White LJ, Hodge DO, Dalvin LA. Incidence and clinical characteristics of pediatric ocular tumors in a Midwestern US population. J AAPOS. 2023 Aug; 27 (4):189.e1-189.e5 Epub 2023 July 13
    View PubMed
  41. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Iezzi R, Bakri SJ. Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota. Eye (Lond). 2023 Jun; 37(9):1861-1865. Epub 2022 Sep 23.
    View PubMed
  42. Tailor PD, Smith WM, Dalvin LA. Blurred Vision After a Kidney Transplant. JAMA Ophthalmol. 2023 May 01; 141(5):494-495.
    View PubMed
  43. Magazin M, Dalvin LA, Salomao DR, Castner NB, Halbach C, Tooley AA. Sebaceous Carcinoma of the Eyelid: Proposed Nomenclature for Multifocal and Multicentric Disease. Ophthalmic Plast Reconstr Surg. 2023 Mar-Apr 01; 39(2):117-122. Epub 2022 Oct 20.
    View PubMed
  44. Kaplan TM, Salomao DR, Dalvin LA. An Amelanotic Choroidal Lesion in a 68-Year-Old Man. JAMA Ophthalmol. 2023 Feb 01; 141(2):206-207.
    View PubMed
  45. Dalvin LA, Pulido JS, Shields CL, Marchese A, Miserocchi E, Frenkel S, Pe'er J. Vitreoretinal lymphoma: Central nervous system lymphoma risk with unilateral or bilateral ocular tumour. A multicentre collaboration. Eye (Lond). 2023 Jan; 37 (1):54-61 Epub 2022 Jan 09
    View PubMed
  46. Shah SM, Boopathiraj N, Starr MR, Dalvin LA, AbouChehade J, Damento G, Garcia MD, Hodge DO, Bakri SJ, Sit AJ, Iezzi R. Risk, Prevalence, and Progression of Glaucoma in Eyes With Age-Related Macular Degeneration Treated With Intravitreal Anti-Vascular Endothelial Growth Factor Injections. Am J Ophthalmol. 2022 Nov; 243:98-108. Epub 2022 Aug 03.
    View PubMed
  47. Guner MK, Ferenchak K, Olsen TW, Dalvin LA. OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CHOROIDAL MELANOMA-ASSOCIATED SUBRETINAL FLUID. Retina. 2022 Nov 1; 42 (11):2159-2168
    View PubMed
  48. Castillejo Becerra CM, Smith WM, Dalvin LA. Ophthalmic adverse effects of BRAF inhibitors. Eur J Ophthalmol. 2022 Oct 11; 11206721221132872. [Epub ahead of print]
    View PubMed
  49. Kasetty VM, Tran AQ, Rosenbaum PS, Dalvin LA, Tooley AA. Uveal melanoma presenting as panophthalmitis in the absence of an intraocular mass. Can J Ophthalmol 2022 Aug; 57 (4):e138-e140 Epub 2021 Oct 26
    View PubMed
  50. Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Gutierrez-Sacristan A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L'Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M, Cai T, South AM, Kohane IS, Weber GM, Consortium for Clinical Characterization of COVID-19 by EHR (4CE). International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med. 2022 Jun 29; 5 (1):81 Epub 2022 June 29
    View PubMed
  51. Oyemade KA, Stafford SL, Gertz MA, Patel SV, Baratz KH, Dalvin LA. Intraocular plasmacytoma: A case of iris involvement and a review of the literature. Am J Ophthalmol Case Rep. 2022 Jun; 26:101533 Epub 2022 Apr 10
    View PubMed
  52. Dalvin LA, Olsen TW, Bakri SJ, McCullough K, Tefferi A, Al-Kali A. Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. Am J Ophthalmol Case Rep. 2022 Jun; 26:101554 Epub 2022 Apr 21
    View PubMed
  53. Lally SE, Milman T, Orloff M, Dalvin LA, Eberhart CG, Heaphy CM, Rodriguez FJ, Lin CC, Dockery PW, Shields JA, Shields CL. Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Ophthalmology. 2022 Jun; 129 (6):679-693 Epub 2022 Jan 24
    View PubMed
  54. Dominguez-Varela IA, Aguilera-Partida JA, Dalvin LA, Garza-Garza LA, Thompson-Garcia LM, Barbosa-Quintana A, Ancona-Lezama D. Retinoblastoma in an older Hispanic child masquerading as pars planitis: A case report. Eur J Ophthalmol. 2022 May; 32 (3):NP71-NP74 Epub 2021 Feb 10
    View PubMed
  55. Joseph AK, Guerin JB, Eckel LJ, Dalvin LA, Keating GF, Liebo GB, Benson JC, Brinjikji W, Laack NN, Silvera VM. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics. Radiographics. 2022 May-Jun; 42 (3):880-897 Epub 2022 Mar 04
    View PubMed
  56. Dalvin LA, Deufel CL, Corbin KS, Petersen IA, Olsen TW, Roddy GW. Postradiation Optic Atrophy Is Associated With Intraocular Pressure and May Manifest With Neuroretinal Rim Thinning. J Neuroophthalmol. 2022 Mar 1; 42 (1):e159-e172 Epub 2021 Nov 11
    View PubMed
  57. Willett KL, Dalvin LA, Pritt BS, Fida M, Kasten MJ, Olsen TW. Cryptococcus gattii endogenous chorioretinitis. Am J Ophthalmol Case Rep. 2022 Mar; 25:101283 Epub 2022 Jan 20
    View PubMed
  58. Pacheco RR, Yaghy A, Dalvin LA, Vaidya S, Perez AL, Lally SE, Shields JA, Shields CL. Conjunctival melanoma: outcomes based on tumour origin in 629 patients at a single ocular oncology centre. Eye (Lond). 2022 Mar; 36 (3):603-611 Epub 2021 Mar 26
    View PubMed
  59. Witsberger EM, Dalvin LA, Patel SV. Visualizing Ocular Surface Squamous Neoplasia. Ophthalmology. 2022 Feb; 129 (2):146
    View PubMed
  60. Fortes BH, Tailor PD, Dalvin LA. Correction to: Ocular Toxicity of Targeted Anticancer Agents. Drugs. 2022 Feb; 82 (3):355
    View PubMed
  61. Ida CM, Pulido J, Greipp PT, Garcia JJ, Olsen TW, Dalvin L, Salomao DR. BAP1 Immunostain Status in Intraocular Biopsy Specimens for Uveal Melanoma Highly Correlates with Other Prognostic Markers. Ocul Oncol Pathol. 2022 Feb; 8 (1):22-29 Epub 2021 Nov 15
    View PubMed
  62. Castillejo Becerra CM, Dalvin LA, Jevremovic D, Hodge DO, Tooley AA. Clinical characteristics and outcomes of ocular adnexal mantle cell lymphoma. Orbit. 2022 Feb; 41 (1):97-104 Epub 2022 Jan 04
    View PubMed
  63. Peddada K, Dalvin LA, Mashayekhi A, Shields CL. DIAGNOSTIC CHALLENGES IN NECROTIC UVEAL MELANOMA. Retin Cases Brief Rep. 2022 Jan 1; 16 (1):92-94
    View PubMed
  64. Fortes BH, Liou H, Dalvin LA. Ophthalmic adverse effects of taxanes: The Mayo Clinic experience. Eur J Ophthalmol. 2022 Jan; 32 (1):602-611 Epub 2020 Nov 04
    View PubMed
  65. Ortiz-Morales G, Dominguez-Varela I, Gomez-Elizondo DE, Perez-Ramos E, Gonzalez-Godinez S, y Mendez DA, Estrada-Hernandez C, Corral R, Zamorano-Gomez O, Shields CL, Dalvin LA, Gonzalez-Monroy E, Ancona-Lezama D. CyberKnife robotic-assisted stereotactic radiosurgery for advanced stages of ciliochoroidal uveal melanoma. Preliminary results in Mexico. Revista Mexicana de Oftalmologia. 2022; 96 (5):201-8
  66. Claxton MR, Dalvin LA, Guo R, Tooley AA. Genetic Alterations in Melanocytoma Associated with Oculodermal Melanocytosis: Molecular Characteristics. Ophthalmic Plast Reconstr Surg. 2021 Dec 16 [Epub ahead of print]
    View PubMed
  67. Fortes BH, Dalvin LA, Hogan WJ, Patnaik MM, Choong GM, Salomao DR, Barkmeier AJ, Bhatti MT. Isolated T-cell acute lymphoblastic leukemic optic disc infiltration. Am J Hematol. 2021 Dec 1; 96 (12):1717-1718 Epub 2021 Sept 30
    View PubMed
  68. Deufel CL, Dalvin LA, Qian J, Vaishnav B, Cutsinger JM, Wittich MN, Petersen IA. How to design, fabricate, and validate a customized COMS-style eye plaque: Illustrated with a narrow-slotted plaque example. Brachytherapy. 2021 Nov-Dec; 20 (6):1235-1244 Epub 2021 July 01
    View PubMed
  69. Dalvin LA, Sit AJ, Patel SV, Roddy GW. Preoperative testing for COVID-19 in an academic ophthalmology practice. J Cataract Refract Surg 2021 Nov 1; 47 (11):1483-1484
    View PubMed
  70. Xu TT, Pulido JS, Parney IF, Ida CM, Dalvin LA, Olsen TW. Carbon Fiducial Markers for Tumor Localization in Stereotactic Irradiation of Uveal Melanoma. Ocul Oncol Pathol. 2021 Oct; 7 (5):368-375 Epub 2021 Aug 03
    View PubMed
  71. Xu TT, Pulido JS, Deufel CL, Corbin KS, Petersen IA, Dalvin LA. Clinical outcomes of Modified Collaborative Ocular Melanoma Study IRIS plaques for treatment of iris, iridociliary, and ciliary body melanoma. Eye (Lond). 2021 Oct; 35 (10):2754-2762 Epub 2020 Nov 24
    View PubMed
  72. Vaidya S, Dalvin LA, Yaghy A, Pacheco R, Shields JA, Lally SE, Shields CL. Conjunctival melanoma: Risk factors for recurrent or new tumor in 540 patients at a single ocular oncology center. Eur J Ophthalmol. 2021 Sep; 31 (5):2675-2685 Epub 2020 Nov 11
    View PubMed
  73. Astafurov KV, Bothun ED, Laack NN, Deisher AJ, Patel SV, Dalvin LA. Ultra-low-dose (boom-boom) radiotherapy for management of recurrent ocular post-transplant lymphoproliferative disorder. Am J Ophthalmol Case Rep. 2021 Sep; 23:101118 Epub 2021 May 15
    View PubMed
  74. Fortes BH, Liou H, Dalvin LA. Ophthalmic adverse effects of immune checkpoint inhibitors: the Mayo Clinic experience. Br J Ophthalmol. 2021 Sep; 105 (9):1263-1271 Epub 2020 Aug 23
    View PubMed
  75. Tanke LB, Leske DA, Dalvin LA. Conversion Factor for B-Scan Ultrasound Measurement of Intraocular Tumors With and Without the Sclera. J Ultrasound Med. 2021 Sep; 40 (9):1911-1917 Epub 2020 Dec 04
    View PubMed
  76. Patel SV, Dalvin LA. Corneal Epitheliopathy Associated With Antibody-Drug Conjugates. Mayo Clin Proc. 2021 Jul; 96 (7):2001-2002
    View PubMed
  77. Sweid A, El Naamani K, Sajja KC, Hammoud B, Knapp MD, Moylan DD, Joffe D, Morse CE, Habbal D, Weinberg JH, Tjoumakaris SI, Shields CL, Lezama DA, Lim LS, Dalvin LA, Rosenwasser R, Jabbour P. Incidence and predictors of ophthalmic artery occlusion in intra-arterial chemotherapy for retinoblastoma. J Neurointerv Surg. 2021 Jul; 13 (7):652-656 Epub 2020 Oct 29
    View PubMed
  78. Shah SM, Barkmeier AJ, Dalvin LA, Tooley AA. Applicant Perceptions Regarding the 2020 to 2021 Virtual Ophthalmology Residency Interview and Match Season. J Acad Ophthalmol (2017). 2021 Jul; 13 (2):e144-e150 Epub 2021 Nov 10
    View PubMed
  79. Fortes BH, Dalvin LA, Bakri SJ. Multimodal imaging of sclerochoroidal calcification associated with choroidal neovascular membrane. Can J Ophthalmol 2021 Jun; 56 (3):e98-e101 Epub 2020 Nov 26
    View PubMed
  80. Dalvin LA, Pennington JD, Mashayekhi A, Shields CL. MULTIMODAL IMAGING OF MACULAR CHOROIDAL MACROVESSEL: A REPORT OF TWO CASES. Retin Cases Brief Rep. 2021 May 1; 15 (3):218-223
    View PubMed
  81. Fortes BH, Tailor PD, Dalvin LA. Ocular Toxicity of Targeted Anticancer Agents. Drugs. 2021 May; 81 (7):771-823 Epub 2021 Mar 31
    View PubMed
  82. Dalvin LA, Yaghy A, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA, Shields CL. Conjunctival Melanoma: Outcomes Based on Age at Presentation in 629 Patients at a Single Ocular Oncology Center. Cornea. 2021 May 1; 40 (5):554-563
    View PubMed
  83. Xu TT, Moser JC, Dalvin LA. Uveal melanoma: laboratory advances and new frontiers in patient care. Curr Opin Ophthalmol. 2021 May 1; 32 (3):301-308
    View PubMed
  84. Dominguez-Varela IA, Ancona-Lezama DA, Dalvin LA, Perez-Ramos EE. Choroidal melanoma treatment in times of coronavirus disease 2019. Melanoma Res 2021 Apr 1; 31 (2):194-195
    View PubMed
  85. Ferenchak K, Dao LN, Dalvin LA. Ocular Relapse of B-Cell Acute Lymphoblastic Leukemia. JAMA Ophthalmol. 2021 Apr 1; 139 (4):e210514 Epub 2021 Apr 21
    View PubMed
  86. Silvera VM, Guerin JB, Brinjikji W, Dalvin LA. Retinoblastoma: What the Neuroradiologist Needs to Know. AJNR Am J Neuroradiol. 2021 Apr; 42 (4):618-626 Epub 2021 Jan 28
    View PubMed
  87. Yang X, Dalvin LA, Lim LS, Mashayekhi A, Shields JA, Shields CL. Ultra-low-dose (boom-boom) radiotherapy for choroidal lymphoma in three consecutive cases. Eur J Ophthalmol. 2021 Mar; 31 (2):NP91-NP96 Epub 2019 Nov 24
    View PubMed
  88. Shields CL, Constantinescu AB, Paulose SA, Yaghy A, Dalvin LA, Shields JA, Lally SE. Primary treatment of ocular surface squamous neoplasia with topical interferon alpha-2b: Comparative analysis of outcomes based on original tumor configuration. Indian J Ophthalmol. 2021 Mar; 69 (3):563-567
    View PubMed
  89. Shields CL, Lally SE, Dalvin LA, Sagoo MS, Pellegrini M, Kaliki S, Gunduz AK, Furuta M, Mruthyunjaya P, Fung AT, Duker JS, Selig SM, Yaghy A, Ferenczy SR, Eydelman MB, Blumenkranz MS. White Paper on Ophthalmic Imaging for Choroidal Nevus Identification and Transformation into Melanoma. Transl Vis Sci Technol. 2021 Feb 5; 10 (2):24
    View PubMed
  90. Mashayekhi A, Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Shields CL, Shields JA. ASSOCIATION OF VITREORETINAL LYMPHOMA WITH SYSTEMIC LYMPHOMA. Retina. 2021 Feb 1; 41 (2):259-265
    View PubMed
  91. Yang X, Dalvin LA, Mazloumi M, Ferenczy S, Lim LS, Ancona-Lezama D, Shields JA, Mashayekhi A, Shields CL. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES. Retina. 2021 Feb 1; 41 (2):249-258
    View PubMed
  92. Bas Z, Dalvin LA, Tadepalli S, Rao R, Shah A, Leahey AM, Shields CL. Outcomes of Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma Based on Patient Age in 964 Eyes of 554 Patients. Asia Pac J Ophthalmol (Phila). 2021 Jan 19; 10 (4):373-380
    View PubMed
  93. Deufel CL, McCauley Cutsinger S, Corbin KS, Dalvin LA, Petersen IA. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for (125)I Collaborative Ocular Melanoma Study eye plaques. Brachytherapy. 2021 Jan-Feb; 20 (1):189-199 Epub 2020 Nov 10
    View PubMed
  94. Shields CL, Yaghy A, Dalvin LA, Vaidya S, Pacheco RR, Perez AL, Lally SE, Shields JA. Conjunctival Melanoma: Outcomes based on the American Joint Committee on Cancer Clinical Classification (8th Edition) of 425 Patients at a Single Ocular Oncology Center. Asia Pac J Ophthalmol (Phila). 2020 Dec 9 Epub 2020 Dec 09
    View PubMed
  95. Shields CL, Paulose SA, Yaghy A, Dalvin LA, Constantinescu AB, Lally SE, Shields JA. Ocular Surface Squamous Neoplasia Managed With Primary Interferon alpha2b: A Comparative Analysis of 212 Tumors in Smokers Versus Nonsmokers. Cornea. 2020 Dec 3 Epub 2020 Dec 03
    View PubMed
  96. Yaghy A, Dalvin LA, Shields CL. A Hidden Pandemic. AMA J Ethics. 2020 Dec 1; 22 (12):E1067-1070 Epub 2020 Dec 01
    View PubMed
  97. Iezzi LA, Dalvin LA. Optical Path Redirection Device for Optical Coherence Tomography Angiography of Recumbent Patients Under General Anesthesia. Transl Vis Sci Technol. 2020 Dec; 9 (13):45 Epub 2020 Dec 29
    View PubMed
  98. Zhang HG, Moser JC, Dalvin LA. Characterization of uveal melanoma clinical trial design: a systematic review to establish an elusive standard of care. Acta Oncol. 2020 Nov; 59 (11):1401-1408 Epub 2020 July 01
    View PubMed
  99. Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: A 2020 review. Indian J Ophthalmol. 2020 Nov; 68 (11):2356-2365
    View PubMed
  100. Sweid A, Hammoud B, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Tjoumakaris S, Shields CL, Ancona-Lezama D, Lim LS, Dalvin LA, Maamari DJ, Jabbour P. The Use of Alternative Routes for the Delivery of Intra-Arterial Chemotherapy for Retinoblastoma. Neurosurgery. 2020 Oct 15; 87 (5):956-963
    View PubMed
  101. Mazloumi M, Dalvin LA, Abtahi SH, Yavari N, Yaghy A, Mashayekhi A, Shields JA, Shields CL. Photodynamic Therapy in Ocular Oncology. J Ophthalmic Vis Res. 2020 Oct-Dec; 15 (4):547-558 Epub 2020 Oct 25
    View PubMed
  102. Yu MD, Dalvin LA, Shields CL. RETINAL CAVERNOUS HEMANGIOMA WITH INTRALESIONAL PHLEBOLITHS. Retin Cases Brief Rep. 2020 Fall; 14 (4):301-304
    View PubMed
  103. Dalvin LA, Spaide RF, Yannuzzi LA, Freund KB, Pulido JS. HYDRATION FOLDS IN RHEGMATOGENOUS RETINAL DETACHMENT. Retin Cases Brief Rep. 2020 Fall; 14 (4):355-359
    View PubMed
  104. Sweid A, Hammoud B, Weinberg JH, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Tjoumakaris SI, Shields CL, Lezama DA, Lim LS, Dalvin LA, El Naamani K, Jabbour P. Ophthalmic artery catheterization for retinoblastoma treatment: does reflux affect tumor response? J Neurointerv Surg. 2020 Sep; 12 (9):915-920 Epub 2020 Apr 09
    View PubMed
  105. Yu MD, Dalvin LA, Ancona-Lezama D, Yaghy A, Ferenczy SR, Milman T, Eagle RC Jr, Shields CL. Choriocapillaris Compression Correlates with Choroidal Nevus-Associated Subretinal Fluid: OCT Analysis of 3431 Cases. Ophthalmology. 2020 Sep; 127 (9):1273-1276 Epub 2020 Mar 27
    View PubMed
  106. Sweid A, Hammoud B, Weinberg JH, Texakalidis P, Xu V, Shivashankar K, Baldassari MP, Das S, Ramesh S, Tjoumakaris S, Shields CL, Ancona-Lezama D, Lim LS, Dalvin LA, Jabbour P. Intra-Arterial Chemotherapy for Retinoblastoma in Infants View PubMed
  107. Yang X, Dalvin LA, Mazloumi M, Chang M, Shields JA, Mashayekhi A, Shields CL. Impact of uveal melanoma thickness on post-plaque radiotherapy outcomes in the prophylactic anti-vascular endothelial growth factor era in 1131 patients. Clin Exp Ophthalmol. 2020 Jul; 48 (5):610-623 Epub 2020 Apr 28
    View PubMed
  108. Dalvin LA, Bas Z, Tadepalli S, Rao R, Vaidya S, Pacheco R, Shields CL. Risk Factors for Tumor Recurrence Following Primary Intravenous Chemotherapy (Chemoreduction) for Retinoblastoma in 869 Eyes of 551 Patients. J Pediatr Ophthalmol Strabismus. 2020 Jul 1; 57 (4):224-234
    View PubMed
  109. Yaghy A, Yu MD, Dalvin LA, Mazloumi M, Ferenczy SR, Shields CL. Photoreceptor morphology and correlation with subretinal fluid chronicity associated with choroidal nevus. Br J Ophthalmol. 2020 Jun; 104 (6):863-867 Epub 2019 Sept 18
    View PubMed
  110. Mazloumi M, Dalvin LA, Ancona-Lezama D, Mashayekhi A, Shields CL. PHOTODYNAMIC THERAPY FOR EXTRAFOVEOLAR CHOROIDAL OSTEOMA. Retina. 2020 May; 40 (5):966-971
    View PubMed
  111. Shah SM, Starr MR, Dalvin LA, Comfere NI, AbouChehade JE, Hodge DO, Iezzi R, Bakri SJ. INCREASED INCIDENCE OF CUTANEOUS KERATINOCYTIC AND MELANOCYTIC MALIGNANCIES IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION. Retina. 2020 May; 40 (5):857-865
    View PubMed
  112. Dalvin LA, Zhang Q, Hamershock RA, Chang M, Yu MD, Mashayekhi A, Shields CL. Nomogram for visual acuity outcome after iodine-125 plaque radiotherapy and prophylactic intravitreal bevacizumab for uveal melanoma in 1131 patients. Br J Ophthalmol. 2020 May; 104 (5):697-702 Epub 2019 Aug 13
    View PubMed
  113. Vichitvejpaisal P, Dalvin LA, Lally SE, Shields CL. Delayed implant infection with Cutibacterium acnes (Propionibacterium acnes) 30 years after silicone sheet orbital floor implant. Orbit. 2020 Apr; 39 (2):139-142 Epub 2019 Apr 25
    View PubMed
  114. Rihani HT, Dalvin LA, Hodge DO, Pulido JS. Incidence of Sturge-Weber syndrome and associated ocular involvement in Olmsted County, Minnesota, United States. Ophthalmic Genet. 2020 Apr; 41 (2):108-124 Epub 2020 Mar 31
    View PubMed
  115. Shields CL, Yaghy A, Dalvin LA, Vaidya S, Pacheco RR, Perez AL, Ramesh S, George K, Arias DE, Shiuey EJ, Lally SE, Shields JA. Conjunctival Melanoma: Features and Outcomes Based on the Fitzpatrick Skin Type in 540 Patients at a Single Ocular Oncology Center. Ophthalmic Plast Reconstr Surg. 2020 Mar 2 Epub 2020 Mar 02
    View PubMed
  116. Mazloumi M, Vichitvejpaisal P, Dalvin LA, Yaghy A, Ewens KG, Ganguly A, Shields CL. Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma. JAMA Ophthalmol. 2020 Mar 1; 138 (3):260-267
    View PubMed
  117. Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Porcu P, Martinez NL, Glass J, Mashayekhi A, Shields CL. Clinical Features Predictive of Survival in Patients With Vitreoretinal Lymphoma: Analysis of 70 Patients at a Single Ocular Oncology Center. Asia Pac J Ophthalmol (Phila). 2020 Mar-Apr; 9 (2):110-116
    View PubMed
  118. Shields CL, Bas Z, Tadepalli S, Dalvin LA, Rao R, Schwendeman R, Lally SE, Shields JA, Shah A, Leahey A. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre. Br J Ophthalmol. 2020 Feb 12 [Epub ahead of print]
    View PubMed
  119. Dalvin LA, Yu MD, Ancona-Lezama DA, Pulido JS, Olsen TW, Shields CL. Retinal haemangioblastoma associated with peripheral non-perfusion: widefield fluorescein angiography analysis of 41 cases. Br J Ophthalmol. 2020 Feb; 104 (2):167-172 Epub 2019 May 16
    View PubMed
  120. Shields CL, Dalvin LA, Chang M, Mazloumi M, Fortin P, McGarrey M, Martin A, Yaghy A, Yang X, Vichitvejpaisal P, Mashayekhi A, Shields JA. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals. JAMA Ophthalmol. 2020 Feb 1; 138 (2):136-146
    View PubMed
  121. Chang M, Dalvin LA, Mazloumi M, Martin A, Yaghy A, Yang X, Bakhtiari S, Li L, Jennings E, Mashayekhi A, Shields CL. Prophylactic Intravitreal Bevacizumab After Plaque Radiotherapy for Uveal Melanoma: Analysis of Visual Acuity, Tumor Response, and Radiation Complications in 1131 Eyes Based on Patient Age. Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb; 9 (1):29-38
    View PubMed
  122. Shields CL, Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA. Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases. Ophthalmol Retina. 2020 Jan; 4 (1):100-110 Epub 2019 Aug 22
    View PubMed
  123. Dalvin LA, Hartnett ME, Bretz CA, Hann CR, Cui RZ, Marmorstein AD, Sheikh-Hamad D, Fautsch MP, Roddy GW. Stanniocalcin-1 is a Modifier of Oxygen-Induced Retinopathy Severity. Curr Eye Res. 2020 Jan; 45 (1):46-51 Epub 2019 Aug 28
    View PubMed
  124. Ancona-Lezama D, Dalvin LA, Lucio-Alvarez JA, Jabbour P, Shields CL. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments. Retina. 2019 Dec; 39 (12):2264-2272
    View PubMed
  125. Ravindran K, Dalvin LA, Pulido JS, Brinjikji W. Intra-arterial chemotherapy for retinoblastoma: an updated systematic review and meta-analysis. J Neurointerv Surg. 2019 Dec; 11 (12):1266-1272 Epub 2019 May 18
    View PubMed
  126. Lim LS, Dalvin LA, Ancona-Lezama D, Yu MD, Jabbour P, Shields CL. Retinoblastoma vascular perfusion and intra-arterial chemotherapy cycle requirements. Clin Exp Ophthalmol. 2019 Dec; 47 (9):1164-1172 Epub 2019 Sept 04
    View PubMed
  127. Shields CL, Dalvin LA, Vichitvejpaisal P, Mazloumi M, Ganguly A, Shields JA. Prognostication of uveal melanoma is simple and highly predictive using The Cancer Genome Atlas (TCGA) classification: A review. Indian J Ophthalmol. 2019 Dec; 67 (12):1959-1963
    View PubMed
  128. Camp DA, Dalvin LA, Schwendeman R, Lim LS, Shields CL. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras. Indian J Ophthalmol. 2019 Dec; 67 (12):1997-2004
    View PubMed
  129. Marous CL, Shields CL, Yu MD, Dalvin LA, Ancona-Lezama D, Shields JA. Malignant transformation of choroidal nevus according to race in 3334 consecutive patients. Indian J Ophthalmol. 2019 Dec; 67 (12):2035-2042
    View PubMed
  130. Battiston AJ, Dalvin LA, Shields CL. Neurofibromatosis type-1 with retinal microvascular corkscrew tortuosity. Indian J Ophthalmol. 2019 Dec; 67 (12):2054-2055
    View PubMed
  131. Dalvin LA, Mashayekhi A, Shields CL. Diffuse Uveal Melanocytic Proliferation With Primary Vitreoretinal Lymphoma. JAMA Ophthalmol 2019 Dec 1; 137 (12):1466
    View PubMed
  132. Chang M, Lally SE, Dalvin LA, Orloff MM, Shields CL. Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy. Indian J Ophthalmol. 2019 Dec; 67 (12):2071-2073
    View PubMed
  133. Dalvin LA, Lim LS, Ancona-Lezama D, Mazloumi M, Chang M, Mashayekhi A, Shields CL. Tumor Control and Visual Acuity Outcomes in Vitreoretinal Lymphoma with and without Sub-Retinal Pigment Epithelium Infiltration: Analysis of 125 Eyes of 70 Patients at a Single Ocular Oncology Center. Ophthalmol Retina. 2019 Nov; 3 (11):998-1005 Epub 2019 May 29
    View PubMed
  134. Yu MD, Dalvin LA, Shields CL. Optical Coherence Tomography Monitoring in a Patient With Retinoblastoma. JAMA Ophthalmol. 2019 Nov 1; 137 (11):e186243 Epub 2019 Nov 14
    View PubMed
  135. Dalvin LA, Shields CL, Ancona-Lezama DA, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA. Combination of multimodal imaging features predictive of choroidal nevus transformation into melanoma. Br J Ophthalmol. 2019 Oct; 103 (10):1441-1447 Epub 2018 Dec 06
    View PubMed
  136. Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL. Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D. Ophthalmology. 2019 Oct; 126 (10):1445-1453 Epub 2019 Apr 24
    View PubMed
  137. Shields CL, Dalvin LA, Yu MD, Ancona-Lezama D, Di Nicola M, Williams BK, Lucio-Alvarez JA, Ang SM, Maloney SM, Welch RJ, Shields JA. CHOROIDAL NEVUS TRANSFORMATION INTO MELANOMA PER MILLIMETER INCREMENT IN THICKNESS USING MULTIMODAL IMAGING IN 2355 CASES: The 2019 Wendell L. Hughes Lecture. Retina 2019 Oct; 39 (10):1852-1860
    View PubMed
  138. Udyaver S, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Khoo CTL, Shields JA, Shields CL. Predictors of enucleation in Coats disease: analysis of 259 eyes of 259 patients at a single center. J AAPOS. 2019 Oct; 23 (5):266.e1-266.e9 Epub 2019 Sept 12
    View PubMed
  139. Dalvin LA, Udyaver S, Lim LS, Mazloumi M, Atalay HT, Khoo CTL, Shields CL. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases. J Pediatr Ophthalmol Strabismus. 2019 Sep 1; 56 (5):288-296
    View PubMed
  140. Khoo CTL, Dalvin LA, Lim LS, Mazloumi M, Atalay HT, Udyaver S, Shields JA, Shields CL. Factors Predictive of Subretinal Fluid Resolution in Coats Disease: Analysis of 177 Eyes in 177 Patients at a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug; 8 (4):290-297
    View PubMed
  141. Masoomian B, Dalvin LA, Yu MD, Stathopoulos C, Shields CL. Retinoblastoma in older patients: A retrospective comparative analysis of 100 consecutive patients based on age. Saudi J Ophthalmol. 2019 Jul-Sep; 33 (3):243-250 Epub 2019 Aug 27
    View PubMed
  142. Dalvin LA, Lim LS, Chang M, Udyaver S, Mazloumi M, Vichitvejpaisal P, Su GL, Florakis E, Mashayekhi A, Shields JA, Shields CL. Circumscribed choroidal hemangioma: Clinical features and outcomes by age category in 458 cases. Saudi J Ophthalmol. 2019 Jul-Sep; 33 (3):219-228 Epub 2019 July 16
    View PubMed
  143. Damento GM, Pulido JS, Abbott BA, Hodge DO, Dalvin LA. TNF-Alpha Inhibition and Other Immunosuppressants in the Development of Uveal and Cutaneous Melanoma. Mayo Clin Proc. 2019 Jul; 94 (7):1287-1295
    View PubMed
  144. Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, Khoo C, Mazloumi M, Shields JA. Visual acuity outcomes in Coats disease by classification stage in 160 patients. Br J Ophthalmol. 2019 Jun 8 Epub 2019 June 08
    View PubMed
  145. Yaghy AN, Dalvin LA, Shields CL. Retinal elevation in an infant. Indian J Ophthalmol. 2019 Jun; 67 (6):725
    View PubMed
  146. Shields CL, Udyaver S, Dalvin LA, Lim LS, Atalay HT, L Khoo CT, Mazloumi M, Shields JA. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol. 2019 Jun; 67 (6):772-783
    View PubMed
  147. Yu MD, Dalvin LA, Welch RJ, Shields CL. Precision Intravitreal Chemotherapy for Localized Vitreous Seeding of Retinoblastoma. Ocul Oncol Pathol. 2019 Jun; 5 (4):284-289 Epub 2018 Sept 13
    View PubMed
  148. Shields CL, Lim LS, Dalvin LA, Shields JA. Small choroidal melanoma: detection with multimodal imaging and management with plaque radiotherapy or AU-011 nanoparticle therapy. Curr Opin Ophthalmol. 2019 May; 30 (3):206-214
    View PubMed
  149. Dalvin LA, Starr MR, AbouChehade JE, Damento GM, Garcia M, Shah SM, Hodge DO, Meissner I, Bakri SJ, Iezzi R. Association of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration. JAMA Ophthalmol. 2019 May 01; 137(5):483-490.
    View PubMed
  150. Starr MR, Dalvin LA, AbouChehade JE, Damento GM, Garcia MD, Shah SM, Hodge DO, Meissner I, Iezzi R, Bakri SJ. Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmic Surg Lasers Imaging Retina. 2019 May 01; 50(5):e140-e157.
    View PubMed
  151. Sivalingam MD, Dalvin LA, Shields CL, Mashayekhi A, Shields JA. Amelanotic Ciliochoroidal Melanoma in a Patient with Oculocutaneous Albinism. Ocul Oncol Pathol. 2019 Apr; 5 (3):182-185 Epub 2018 Sept 03
    View PubMed
  152. Ancona-Lezama DA, Dalvin LA, Lucio-Alvarez JA, Jabbour P, Shields CL. Choroidal Ischemia Sparing the Watershed Zone following Intra-Arterial Chemotherapy for Retinoblastoma. Ocul Oncol Pathol. 2019 Apr; 5 (3):190-194 Epub 2018 Sept 17
    View PubMed
  153. Dalvin LA, Maxfield SD, Salomao DR, Pulido JS. Presumed Choroidal Granuloma Annulare Mimicking Choroidal Lymphoma. Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1; 50 (4):e128-e132
    View PubMed
  154. Gervasio KA, Dalvin LA, Shields CL. Spontaneous Regression of Florid Retinal Neovascularization Following Resolution of Traction Retinal Detachment in an Eye With Treated Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2019 Mar 25; 56:e24-e27
    View PubMed
  155. Camp DA, Yadav P, Dalvin LA, Shields CL. Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol. 2019 Mar; 30 (2):71-81
    View PubMed
  156. Li L, Dalvin LA, Shields CL. Atypical Fundus Mass in a Child. JAMA Ophthalmol. 2019 Mar 1; 137 (3):322-323
    View PubMed
  157. D'Costa MR, Dalvin LA, Manohar S, Maguire LJ, Grande JP, Gonsalves WI, Nasr SH, Hogan MC. Crystalglobulin-Induced Nephropathy and Keratopathy. Kidney Med. 2019 Mar-Apr; 1 (2):71-74 Epub 2019 Feb 25
    View PubMed
  158. Li MM, Dalvin LA, Shields CL. Coexisting White and Dark Without Pressure Abnormalities Surrounding Congenital Hypertrophy of the Retinal Pigment Epithelium. J Pediatr Ophthalmol Strabismus. 2019 Feb 8; 56:e5-e7 Epub 2019 Feb 08
    View PubMed
  159. Dalvin LA, Kumari M, Essuman VA, Shohelly Shipa S, Ancona-Lezama D, Lucio-Alvarez JA, Jabbour P, Shields CL. Primary Intra-Arterial Chemotherapy for Retinoblastoma in the Intravitreal Chemotherapy Era: Five Years of Experience. Ocul Oncol Pathol. 2019 Feb; 5 (2):139-146 Epub 2018 Aug 21
    View PubMed
  160. Ang SM, Dalvin LA, Emrich J, Komarnicky L, Shields JA, Shields CL. Plaque Radiotherapy for Medulloepithelioma in 6 Cases From a Single Center. Asia Pac J Ophthalmol (Phila). 2019 Jan-Feb; 8 (1):30-35 Epub 2018 Oct 30
    View PubMed
  161. Ghassemi F, Khojasteh H, Khodabande A, Dalvin LA, Mazloumi M, Riazi-Esfahani H, Mirghorbani M. Comparison of Three Different Techniques of Inverted Internal Limiting Membrane Flap in Treatment of Large Idiopathic Full-Thickness Macular Hole. Clin Ophthalmol. 2019; 13:2599-2606 Epub 2019 Dec 27
    View PubMed
  162. Shields CL, Dalvin LA, Ancona-Lezama D, Yu MD, Di Nicola M, Williams BK Jr, Lucio-Alvarez JA, Ang SM, Maloney S, Welch RJ, Shields JA. CHOROIDAL NEVUS IMAGING FEATURES IN 3,806 CASES AND RISK FACTORS FOR TRANSFORMATION INTO MELANOMA IN 2,355 CASES: The 2020 Taylor R. Smith and Victor T. Curtin Lecture. Retina. 2018 Dec 31 [Epub ahead of print]
    View PubMed
  163. Dalvin LA, Pulido JS, Shields CL. Clarification on Uveal Melanoma Associated With Myotonic Dystrophy-Reply. JAMA Ophthalmol 2018 Dec 1; 136 (12):1427
    View PubMed
  164. Dalvin LA, Salomao DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol. 2018 Dec; 102 (12):1728-1734 Epub 2018 Mar 06
    View PubMed
  165. Dalvin LA, Ancona-Lezama D, Lucio-Alvarez JA, Masoomian B, Jabbour P, Shields CL. Ophthalmic Vascular Events after Primary Unilateral Intra-arterial Chemotherapy for Retinoblastoma in Early and Recent Eras. Ophthalmology. 2018 Nov; 125 (11):1803-1811 Epub 2018 June 18
    View PubMed
  166. Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: Systemic Indications and Ophthalmic Side Effects. Retina. 2018 Jun; 38 (6):1063-1078
    View PubMed
  167. Dalvin LA, Shields CL, Pulido JS, Sioufi K, Cohen V, Shields JA. Uveal Melanoma Associated With Myotonic Dystrophy: A Report of 6 Cases. JAMA Ophthalmol. 2018 May 1; 136 (5):543-547
    View PubMed
  168. Dalvin LA, Salomão DR, Iezzi R, Barkmeier AJ. Subconjunctival Exposure to Carbopol Causes Chronic Histiocytic Inflammatory Response in Rabbits. Transl Vis Sci Technol. 2018 May; 7(3):9. Epub 2018 May 31.
    View PubMed
  169. Pulido JS, Dalvin LA, Olsen TW, Mano F, Yu M, Shields CL. Peripheral retinal nonperfusion using widefield imaging with von Hippel-Lindau disease. Int J Retina Vitreous. 2018; 4:36 Epub 2018 Oct 03
    View PubMed
  170. Dalvin LA, Damento GM, Yawn BP, Abbott BA, Hodge DO, Pulido JS. Parkinson Disease and Melanoma: Confirming and Reexamining an Association. Mayo Clin Proc. 2017 Jul; 92 (7):1070-1079
    View PubMed
  171. Adeyemo O, Jeter PE, Rozanski C, Arnold E, Dalvin LA, Swenor B, Dagnelie G, PLoVR Study Group. Living with Ultra-Low Vision: An Inventory of Self-Reported Visually Guided Activities by Individuals with Profound Visual Impairment. Transl Vis Sci Technol. 2017 May; 6 (3):10 Epub 2017 May 31
    View PubMed
  172. Dalvin LA, Smith WM. Intraocular manifestations of mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Other Mycobact Dis. 2017 May; 7:13-21 Epub 2017 Feb 17
    View PubMed
  173. Dalvin LA, Pulido JS, Marmorstein AD. Vitelliform dystrophies: Prevalence in Olmsted County, Minnesota, United States. Ophthalmic Genet. 2017 Mar-Apr; 38 (2):143-147 Epub 2016 Apr 27
    View PubMed
  174. Dalvin LA, Fervenza FC, Sethi S, Pulido JS. SHEDDING LIGHT ON FUNDUS DRUSEN ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS: BREAKING STEREOTYPES OF TYPES I, II, AND III. Retin Cases Brief Rep. 2016 Winter; 10 (1):72-8
    View PubMed
  175. Dalvin LA, Garcia MD, Salomão DR, Iezzi R, Barkmeier AJ. Necrotizing Subconjunctival Granulomata and Intraoperative Use of Topical GenTeal Gel. Ophthalmology. 2016 Oct; 123(10):2262-3. Epub 2016 Jun 17.
    View PubMed
  176. Dalvin LA, Smith WM. Orbital and external ocular manifestations of Mycobacterium tuberculosis: A review of the literature. J Clin Tuberc Other Mycobact Dis. 2016 Aug; 4:50-57 Epub 2015 Nov 27
    View PubMed
  177. Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Manifestations of Complement-Mediated and Immune Complex-Mediated Membranoproliferative Glomerulonephritis: A Comparative Consecutive Series. Ophthalmology. 2016 Jul; 123 (7):1588-94 Epub 2016 Mar 18
    View PubMed
  178. Dalvin LA, Abou Chehade JE, Chiang J, Fuchs J, Iezzi R, Marmorstein AD. Retinitis pigmentosa associated with a mutation in BEST1. Am J Ophthalmol Case Rep. 2016 Jul; 2:11-17. Epub 2016 Mar 30.
    View PubMed
  179. Dalvin LA, Thom SB, Garcia JJ, Fadel HJ, Baratz KH. Scleritis Due to Histoplasmosis. Cornea. 2016 Mar; 35: (3)402-4.
    View PubMed
  180. Dalvin LA, Johnson AA, Pulido JS, Dhaliwal R, Marmorstein AD. Nonantibestrophin Anti-RPE Antibodies in Paraneoplastic Exudative Polymorphous Vitelliform Maculopathy. Transl Vis Sci Technol. 2015 May; 4 (3):2 Epub 2015 May 15
    View PubMed
  181. Dalvin LA, Fautsch MP. Analysis of Circadian Rhythm Gene Expression With Reference to Diurnal Pattern of Intraocular Pressure in Mice. Invest Ophthalmol Vis Sci. 2015 Apr 1; 56(4):2657-63.
    View PubMed
  182. Sweiss RB, Shweikeh F, Sweiss FB, Zyck S, Dalvin L, Siddiqi J. Suprasellar mature cystic teratoma: an unusual location for an uncommon tumor. Case Rep Neurol Med. 2013; 2013:180497 Epub 2013 Oct 02
    View PubMed